-
1
-
-
84862952700
-
Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy: Results from the Prostate Cancer Results Study Group
-
P. Grimm, I. Billiet, and D. Bostwick Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy: results from the Prostate Cancer Results Study Group BJU Int 109 suppl 1) 2012 22 29
-
(2012)
BJU Int
, vol.109
, Issue.SUPPL. 1
, pp. 22-29
-
-
Grimm, P.1
Billiet, I.2
Bostwick, D.3
-
2
-
-
40949147326
-
Quality of life and satisfaction with outcome among prostate-cancer survivors
-
M.G. Sanda, R.L. Dunn, and J. Michalski Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
-
(2008)
N Engl J Med
, vol.358
, pp. 1250-1261
-
-
Sanda, M.G.1
Dunn, R.L.2
Michalski, J.3
-
3
-
-
79960077352
-
10-Year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: Results for 1,100 patients
-
J. Crook, J. Borg, and A. Evans 10-Year experience with I-125 prostate brachytherapy at the Princess Margaret Hospital: results for 1,100 patients Int J Radiat Oncol Biol Phys 80 2011 1323 1329
-
(2011)
Int J Radiat Oncol Biol Phys
, vol.80
, pp. 1323-1329
-
-
Crook, J.1
Borg, J.2
Evans, A.3
-
4
-
-
84858405681
-
Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer
-
A.M. Emara, E. Chadwick, and J.P. Nobes Long-term toxicity and quality of life up to 10 years after low-dose rate brachytherapy for prostate cancer BJU Int 109 2012 994 1000
-
(2012)
BJU Int
, vol.109
, pp. 994-1000
-
-
Emara, A.M.1
Chadwick, E.2
Nobes, J.P.3
-
5
-
-
83555160931
-
Factors influencing urinary symptoms 10 years after permanent prostate seed implantation
-
N.N. Stone, N.K. Gerber, and S. Blacksburg Factors influencing urinary symptoms 10 years after permanent prostate seed implantation J Urol 187 2012 117 123
-
(2012)
J Urol
, vol.187
, pp. 117-123
-
-
Stone, N.N.1
Gerber, N.K.2
Blacksburg, S.3
-
6
-
-
33847080897
-
Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years
-
N.N. Stone, and R.G. Stock Long-term urinary, sexual, and rectal morbidity in patients treated with iodine-125 prostate brachytherapy followed up for a minimum of 5 years Urology 69 2007 338 342
-
(2007)
Urology
, vol.69
, pp. 338-342
-
-
Stone, N.N.1
Stock, R.G.2
-
7
-
-
79951989027
-
Impact of age at diagnosis on prostate cancer treatment and survival
-
S.K. Bechis, P.R. Carroll, and M.R. Cooperberg Impact of age at diagnosis on prostate cancer treatment and survival J Clin Oncol 29 2011 235 241
-
(2011)
J Clin Oncol
, vol.29
, pp. 235-241
-
-
Bechis, S.K.1
Carroll, P.R.2
Cooperberg, M.R.3
-
8
-
-
77950349543
-
Physician visits prior to treatment for clinically localized prostate cancer
-
T.L. Jang, J.E. Bekelman, and Y. Liu Physician visits prior to treatment for clinically localized prostate cancer Arch Intern Med 170 2010 440 450
-
(2010)
Arch Intern Med
, vol.170
, pp. 440-450
-
-
Jang, T.L.1
Bekelman, J.E.2
Liu, Y.3
-
9
-
-
81855194125
-
Treatment decision-making for localized prostate cancer: What younger men choose and why
-
A. Sidana, D.J. Hernandez, and Z. Feng Treatment decision-making for localized prostate cancer: what younger men choose and why Prostate 72 2012 58 64
-
(2012)
Prostate
, vol.72
, pp. 58-64
-
-
Sidana, A.1
Hernandez, D.J.2
Feng, Z.3
-
10
-
-
0038299194
-
Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis
-
S.B. Zeliadt, D.F. Penson, and P.C. Albertsen Race independently predicts prostate specific antigen testing frequency following a prostate carcinoma diagnosis Cancer 98 2003 496 503
-
(2003)
Cancer
, vol.98
, pp. 496-503
-
-
Zeliadt, S.B.1
Penson, D.F.2
Albertsen, P.C.3
-
11
-
-
30544440136
-
Biologically effective dose values for prostate brachytherapy: Effects on PSA failure and posttreatment biopsy results
-
R.G. Stock, N.N. Stone, J.A. Cesaretti, and B.S. Rosenstein Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results Int J Radiat Oncol Biol Phys 64 2006 527 533
-
(2006)
Int J Radiat Oncol Biol Phys
, vol.64
, pp. 527-533
-
-
Stock, R.G.1
Stone, N.N.2
Cesaretti, J.A.3
Rosenstein, B.S.4
-
12
-
-
33846632262
-
Assessment of postbrachytherapy sexual function: A comparison of the IIEF-5 and the MSEFS
-
T.M. Zagar, R.G. Stock, J.A. Cesaretti, and N.N. Stone Assessment of postbrachytherapy sexual function: a comparison of the IIEF-5 and the MSEFS Brachytherapy 6 2007 26 33
-
(2007)
Brachytherapy
, vol.6
, pp. 26-33
-
-
Zagar, T.M.1
Stock, R.G.2
Cesaretti, J.A.3
Stone, N.N.4
-
13
-
-
77950487153
-
Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer
-
J.B. Malcolm, M.D. Fabrizio, and B.B. Barone Quality of life after open or robotic prostatectomy, cryoablation or brachytherapy for localized prostate cancer J Urol 183 2010 1822 1828
-
(2010)
J Urol
, vol.183
, pp. 1822-1828
-
-
Malcolm, J.B.1
Fabrizio, M.D.2
Barone, B.B.3
-
14
-
-
77449084627
-
Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer
-
E.M. Roeloffzen, I.M. Lips, and M.P. van Gellekom Health-related quality of life up to six years after (125)I brachytherapy for early-stage prostate cancer Int J Radiat Oncol Biol Phys 76 2010 1054 1060
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.76
, pp. 1054-1060
-
-
Roeloffzen, E.M.1
Lips, I.M.2
Van Gellekom, M.P.3
-
15
-
-
0028835888
-
Community-based population studies on the natural history of prostatism
-
S.J. Jacobsen, J.E. Oesterling, and M.M. Lieber Community-based population studies on the natural history of prostatism Curr Opin Urol 5 1995 13 17
-
(1995)
Curr Opin Urol
, vol.5
, pp. 13-17
-
-
Jacobsen, S.J.1
Oesterling, J.E.2
Lieber, M.M.3
-
16
-
-
84862776904
-
Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate
-
C.A. Lawton, Y. Yan, and W.R. Lee Long-term results of an RTOG Phase II trial (00-19) of external-beam radiation therapy combined with permanent source brachytherapy for intermediate-risk clinically localized adenocarcinoma of the prostate Int J Radiat Oncol Biol Phys 82 2012 e795 e801
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
-
-
Lawton, C.A.1
Yan, Y.2
Lee, W.R.3
-
17
-
-
84863438775
-
Long-term potency preservation following brachytherapy for prostate cancer
-
K.M. Snyder, R.G. Stock, M. Buckstein, and N.N. Stone Long-term potency preservation following brachytherapy for prostate cancer BJU Int 110 2012 221 225
-
(2012)
BJU Int
, vol.110
, pp. 221-225
-
-
Snyder, K.M.1
Stock, R.G.2
Buckstein, M.3
Stone, N.N.4
-
18
-
-
33846578156
-
Prevalence and risk factors for erectile dysfunction in the US
-
E. Selvin, A.L. Burnett, and E.A. Platz Prevalence and risk factors for erectile dysfunction in the US Am J Med 120 2007 151 157
-
(2007)
Am J Med
, vol.120
, pp. 151-157
-
-
Selvin, E.1
Burnett, A.L.2
Platz, E.A.3
-
19
-
-
83255164854
-
Prostate brachytherapy and second primary cancer risk: A competitive risk analysis
-
K.A. Hinnen, M. Schaapveld, and M. van Vulpen Prostate brachytherapy and second primary cancer risk: a competitive risk analysis J Clin Oncol 29 2011 4510 4515
-
(2011)
J Clin Oncol
, vol.29
, pp. 4510-4515
-
-
Hinnen, K.A.1
Schaapveld, M.2
Van Vulpen, M.3
|